(Q35948229)

English

Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

0 references

prostate cancer screening

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

object named as

Hans Lilja

4

0 references

3

object named as

Jonas Hugosson

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Laila Bruun

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Charlotte Becker

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Anders Christensson

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

publication date

1 November 2005

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

65

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

216-221

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951509

2 October 2017

Detection of prostate cancer in men with prostate-specific antigen levels of 2.0 to 4.0 ng/mL equivalent to that in men with 4.1 to 10.0 ng/mL in a Japanese population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951509

2 October 2017

Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951509

2 October 2017

Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951509

2 October 2017

Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951509

2 October 2017

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951509

2 October 2017

Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951509

2 October 2017

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951509

2 October 2017

The importance of imprecision

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951509

2 October 2017

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951509

2 October 2017

Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951509

11 July 2018

Rapid elimination by glomerular filtration of free prostate specific antigen and human kallikrein 2 after renal transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951509

24 September 2018

Use of early PSA velocity to predict eventual abnormal PSA values in men at risk for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951509

24 September 2018

Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951509

24 September 2018

Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations

1 reference

https://pubmed.ncbi.nlm.nih.gov/15948137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Day to day changes in free and total PSA: significance of biological variation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15948137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/15948137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15948137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clearance mechanism of prostate specific antigen and its complexes with alpha2-macroglobulin and alpha1-antichymotrypsin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15948137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml

1 reference

https://pubmed.ncbi.nlm.nih.gov/15948137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/15948137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/15948137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features

1 reference

https://pubmed.ncbi.nlm.nih.gov/15948137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration

1 reference

https://pubmed.ncbi.nlm.nih.gov/15948137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/15948137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/PROS.20286

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35948229&oldid=1982260251"